N-(3-((6-fluoroquinolin-4-yl)oxy)-5-methoxyphenyl)acetamide

ID: ALA5287203

Chembl Id: CHEMBL5287203

Max Phase: Preclinical

Molecular Formula: C18H15FN2O3

Molecular Weight: 326.33

Names and Identifiers

Canonical SMILES:  COc1cc(NC(C)=O)cc(Oc2ccnc3ccc(F)cc23)c1

Standard InChI:  InChI=1S/C18H15FN2O3/c1-11(22)21-13-8-14(23-2)10-15(9-13)24-18-5-6-20-17-4-3-12(19)7-16(17)18/h3-10H,1-2H3,(H,21,22)

Standard InChI Key:  CMPZNSKODXAZEC-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5287203

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 326.33

Molecular Weight (Monoisotopic): 326.1067

AlogP: 4.13

#Rotatable Bonds: 4

Polar Surface Area: 60.45

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 13.56

CX Basic pKa: 4.43

CX LogP: 2.85

CX LogD: 2.85

Aromatic Rings: 3

Heavy Atoms: 24

QED Weighted: 0.78

Np Likeness Score: -1.24

References

1. Lv G, Shi Q, Zhang T, Li J, Long Y, Zhang W, Choudhry N, Yang K, Li H, Kalashova J, Yang C, Zhou X, Reddy MC, Anantoju KK, Zhang S, Zhang J, Allen TD, Liu H, Nimishetti N, Yang D..  (2023)  Integrating a phenotypic screening with a structural simplification strategy to identify 4-phenoxy-quinoline derivatives to potently disrupt the mitotic localization of Aurora kinase B.,  80  [PMID:36696874] [10.1016/j.bmc.2023.117173]

Source

Source(1):

• Scientific Literature